NCT02588989View on ClinicalTrials.gov

Fibrosis, Valvular and Ventricular Function in Patients With TGA

Active, not recruitingOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Transposition of Great Vessels
Trial Locations (1)

3000

University Hospitals Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT02588989 - Fibrosis, Valvular and Ventricular Function in Patients With TGA | Biotech Hunter | Biotech Hunter